Integra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. DPZ
6. DFTX
7. CNC
8. KFY
9. SPY
10. MU

Go back to Integra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance

Integra LifeSciences (IART) Tops Q4 EPS by 1c; Offers 2022 Guidance

February 23, 2022 6:03 AM EST

Integra LifeSciences (NASDAQ: IART) reported Q4 EPS of $0.84, $0.01 better than the analyst estimate of $0.83. Revenue for the quarter came in at $405.5 million versus the consensus estimate of $403.4 million.

GUIDANCE:

Integra LifeSciences sees FY2022 EPS of $3.27-$3.35, versus the consensus of $3.42.... More